M MT1 (Metoprolol succinate extended-release 25 mg)
Pill imprint M MT1 has been identified as Metoprolol succinate extended-release 25 mg.
Metoprolol is used in the treatment of atrial fibrillation; high blood pressure; supraventricular tachycardia; angina; migraine prevention (and more), and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Metoprolol 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for M MT1
- 25 mg
- Prescription only
- Drug Class:
- Cardioselective beta blockers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium stearyl fumarate
More about metoprolol
- Metoprolol succinate extended-release tablets
- Metoprolol (Advanced Reading)
- Metoprolol Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.